BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arnott CH, Scott KA, Moore RJ, Hewer A, Phillips DH, Parker P, Balkwill FR, Owens DM. Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway. Oncogene. 2002;21:4728-4738. [PMID: 12101411 DOI: 10.1038/sj.onc.1205588] [Cited by in Crossref: 126] [Cited by in F6Publishing: 107] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Rundhaug JE, Fischer SM. Molecular mechanisms of mouse skin tumor promotion. Cancers (Basel) 2010;2:436-82. [PMID: 21297902 DOI: 10.3390/cancers2020436] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 11.1] [Reference Citation Analysis]
2 Nishisgori C. Current concept of photocarcinogenesis. Photochem Photobiol Sci 2015;14:1713-21. [DOI: 10.1039/c5pp00185d] [Cited by in Crossref: 58] [Cited by in F6Publishing: 18] [Article Influence: 9.7] [Reference Citation Analysis]
3 Guan Y, Yang YJ, Nagarajan P, Ge Y. Transcriptional and signalling regulation of skin epithelial stem cells in homeostasis, wounds and cancer. Exp Dermatol 2021;30:529-45. [PMID: 33249665 DOI: 10.1111/exd.14247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wang B, Song N, Yu T, Zhou L, Zhang H, Duan L, He W, Zhu Y, Bai Y, Zhu M. Expression of tumor necrosis factor-alpha-mediated genes predicts recurrence-free survival in lung cancer. PLoS One 2014;9:e115945. [PMID: 25548907 DOI: 10.1371/journal.pone.0115945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
5 Garrity-Park MM, Loftus EV Jr, Bryant SC, Sandborn WJ, Smyrk TC. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 2008;103:407-15. [PMID: 18289203 DOI: 10.1111/j.1572-0241.2007.01572.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
6 Nadda N, Setia S, Vaish V, Sanyal SN. Role of cytokines in experimentally induced lung cancer and chemoprevention by COX-2 selective inhibitor, etoricoxib. Mol Cell Biochem 2013;372:101-12. [PMID: 22991065 DOI: 10.1007/s11010-012-1451-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
7 Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71-78. [PMID: 14708027 DOI: 10.1038/nrc1256] [Cited by in Crossref: 2153] [Cited by in F6Publishing: 2034] [Article Influence: 126.6] [Reference Citation Analysis]
8 Karin M. NF-kappaB and cancer: mechanisms and targets. Mol Carcinog. 2006;45:355-361. [PMID: 16673382 DOI: 10.1002/mc.20217] [Cited by in Crossref: 205] [Cited by in F6Publishing: 188] [Article Influence: 13.7] [Reference Citation Analysis]
9 Carlier-Mercier L, Fontaine JL, Boccon-Gibod L, Girardet JP, Josset P, Gouraud F, Pinturier MF. A rare cause of neonatal exudative enteropathy: congenital Langerhans cell histiocytosis (histiocytosis X). Arch Fr Pediatr. 1992;49:199-201. [PMID: 1610278 DOI: 10.1016/j.mrfmmm.2005.04.019] [Cited by in Crossref: 112] [Cited by in F6Publishing: 96] [Article Influence: 3.9] [Reference Citation Analysis]
10 Jurisic V, Bogdanovic G, Kojic V, Jakimov D, Srdic T. Effect of TNF-alpha on Raji cells at different cellular levels estimated by various methods. Ann Hematol 2006;85:86-94. [PMID: 16261372 DOI: 10.1007/s00277-005-0010-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
11 Wu P, Yuan SS, Ho CC, Hsieh WY, Hong QS, Yu SL, Chen W, Chen HY, Wang CD, Li KC, Yang PC, Chen HW. Focal amplification of HOXD-harboring chromosome region is implicated in multiple-walled carbon nanotubes-induced carcinogenicity. Nano Lett 2013;13:4632-41. [PMID: 23984819 DOI: 10.1021/nl401658c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
12 Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Tan BK, Kumar AP, Sethi G. The multifaceted role of curcumin in cancer prevention and treatment. Molecules 2015;20:2728-69. [PMID: 25665066 DOI: 10.3390/molecules20022728] [Cited by in Crossref: 228] [Cited by in F6Publishing: 205] [Article Influence: 38.0] [Reference Citation Analysis]
13 Srinivasan S, Kumar R, Koduru S, Chandramouli A, Damodaran C. Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer. Apoptosis 2010;15:153-61. [PMID: 19851870 DOI: 10.1007/s10495-009-0416-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
14 Shan B, Zhuo Y, Chin D, Morris CA, Morris GF, Lasky JA. Cyclin-dependent Kinase 9 Is Required for Tumor Necrosis Factor-α-stimulated Matrix Metalloproteinase-9 Expression in Human Lung Adenocarcinoma Cells. Journal of Biological Chemistry 2005;280:1103-11. [DOI: 10.1074/jbc.m406293200] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
15 Kang MI, Baker AR, Dextras CR, Cabarcas SM, Young MR, Colburn NH. Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis. Genes Cancer 2012;3:37-50. [PMID: 22893789 DOI: 10.1177/1947601912448820] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
16 Park J, Lee J, Ann S, Seo D, Choi W, Yoo Y, Park S, Choi J, Um S, Ahn S, Han J. A Fermented Ginseng Extract, BST204, Inhibits Proliferation and Motility of Human Colon Cancer Cells. Biomolecules and Therapeutics 2011;19:211-7. [DOI: 10.4062/biomolther.2011.19.2.211] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
17 Cataisson C, Pearson AJ, Tsien MZ, Mascia F, Gao JL, Pastore S, Yuspa SH. CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation. J Clin Invest 2006;116:2757-66. [PMID: 16964312 DOI: 10.1172/JCI27514] [Cited by in Crossref: 62] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
18 Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 2006;25:387-408. [PMID: 17043764 DOI: 10.1007/s10555-006-9004-4] [Cited by in Crossref: 361] [Cited by in F6Publishing: 356] [Article Influence: 25.8] [Reference Citation Analysis]
19 Heger M, van Golen RF, Broekgaarden M, Michel MC. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacol Rev 2014;66:222-307. [PMID: 24368738 DOI: 10.1124/pr.110.004044] [Cited by in Crossref: 275] [Cited by in F6Publishing: 244] [Article Influence: 34.4] [Reference Citation Analysis]
20 Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749-759. [PMID: 16175180 DOI: 10.1038/nri1703] [Cited by in Crossref: 2068] [Cited by in F6Publishing: 1991] [Article Influence: 129.3] [Reference Citation Analysis]
21 Apte RN, Krelin Y, Song X, Dotan S, Recih E, Elkabets M, Carmi Y, Dvorkin T, White RM, Gayvoronsky L. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur J Cancer. 2006;42:751-759. [PMID: 16530403 DOI: 10.1016/j.ejca.2006.01.010] [Cited by in Crossref: 125] [Cited by in F6Publishing: 121] [Article Influence: 8.3] [Reference Citation Analysis]
22 Gubernatorova EO, Polinova AI, Petropavlovskiy MM, Namakanova OA, Medvedovskaya AD, Zvartsev RV, Telegin GB, Drutskaya MS, Nedospasov SA. Dual Role of TNF and LTα in Carcinogenesis as Implicated by Studies in Mice. Cancers (Basel) 2021;13:1775. [PMID: 33917839 DOI: 10.3390/cancers13081775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kim KS, Kim HY, Joe EH, Jou I. Matrix metalloproteinase-3 induction in rat brain astrocytes: focus on the role of two AP-1 elements. Biochem J 2008;410:605-11. [PMID: 18072934 DOI: 10.1042/BJ20071207] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
24 Kulcenty K, Piotrowski I, Wróblewska JP, Wasiewicz J, Suchorska AWM. The Composition of Surgical Wound Fluids from Breast Cancer Patients is Affected by Intraoperative Radiotherapy Treatment and Depends on the Molecular Subtype of Breast Cancer. Cancers (Basel) 2019;12:E11. [PMID: 31861498 DOI: 10.3390/cancers12010011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Corrêa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, dos Santos EP, Silva TF, Gomez RS, Guimarães AL, De Paula AM. Association of -308 TNF-α promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol 2011;47:888-94. [PMID: 21788151 DOI: 10.1016/j.oraloncology.2011.07.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
26 Montesano R, Soulié P, Eble JA, Carrozzino F. Tumour necrosis factor α confers an invasive, transformed phenotype on mammary epithelial cells. Journal of Cell Science 2005;118:3487-500. [DOI: 10.1242/jcs.02467] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
27 Hagemann T, Balkwill F. MIFed about cancer? Gastroenterology 2005;129:1785-7. [PMID: 16285974 DOI: 10.1053/j.gastro.2005.09.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Salako MA, Kulbe H, Ingemarsdotter CK, Pirlo KJ, Williams SL, Lockley M, Balkwill FR, McNeish IA. Inhibition of the inflammatory cytokine TNF-α increases adenovirus activity in ovarian cancer via modulation of cIAP1/2 expression. Mol Ther 2011;19:490-9. [PMID: 21081903 DOI: 10.1038/mt.2010.247] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
29 Farsinejad S, Cattabiani T, Muranen T, Iwanicki M. Ovarian Cancer Dissemination-A Cell Biologist's Perspective. Cancers (Basel) 2019;11:E1957. [PMID: 31817625 DOI: 10.3390/cancers11121957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Kusunoki Y, Hamasaki K, Koyama K, Imai K, Hayashi T, Martin PJ, Nakachi K. Increased DNA damage in hematopoietic cells of mice with graft-versus-host disease. Mutat Res 2010;689:59-64. [PMID: 20471404 DOI: 10.1016/j.mrfmmm.2010.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
31 Mirastschijski U, Lupše B, Maedler K, Sarma B, Radtke A, Belge G, Dorsch M, Wedekind D, McCawley LJ, Boehm G, Zier U, Yamamoto K, Kelm S, Ågren MS. Matrix Metalloproteinase-3 is Key Effector of TNF-α-Induced Collagen Degradation in Skin. Int J Mol Sci 2019;20:E5234. [PMID: 31652545 DOI: 10.3390/ijms20205234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Cheon EC, Strouch MJ, Krantz SB, Heiferman MJ, Bentrem DJ. Genetic deletion of 5-lipoxygenase increases tumor-infiltrating macrophages in Apc(Δ468) mice. J Gastrointest Surg 2012;16:389-93. [PMID: 22072302 DOI: 10.1007/s11605-011-1761-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
33 Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin 2008;29:1275-88. [PMID: 18954521 DOI: 10.1111/j.1745-7254.2008.00889.x] [Cited by in Crossref: 276] [Cited by in F6Publishing: 251] [Article Influence: 23.0] [Reference Citation Analysis]
34 Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG, Balkwill FR. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene. 2004;23:1902-1910. [PMID: 14661063 DOI: 10.1038/sj.onc.1207317] [Cited by in Crossref: 146] [Cited by in F6Publishing: 131] [Article Influence: 8.6] [Reference Citation Analysis]
35 Papp KA. The safety of etanercept for the treatment of plaque psoriasis. Ther Clin Risk Manag 2007;3:245-58. [PMID: 18360633 DOI: 10.2147/tcrm.2007.3.2.245] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
36 Kim S, Han J, Lee DH, Cho KH, Kim KH, Chung JH. Cholesterol, a Major Component of Caveolae, Down-regulates Matrix Metalloproteinase-1 Expression through ERK/JNK Pathway in Cultured Human Dermal Fibroblasts. Ann Dermatol 2010;22:379-88. [PMID: 21165206 DOI: 10.5021/ad.2010.22.4.379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
37 Karin M. The IkappaB kinase - a bridge between inflammation and cancer. Cell Res 2008;18:334-42. [PMID: 18301380 DOI: 10.1038/cr.2008.30] [Cited by in Crossref: 195] [Cited by in F6Publishing: 194] [Article Influence: 15.0] [Reference Citation Analysis]
38 Jung YY, Shanmugam MK, Chinnathambi A, Alharbi SA, Shair OHM, Um JY, Sethi G, Ahn KS. Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways. Molecules 2019;24:E3127. [PMID: 31466313 DOI: 10.3390/molecules24173127] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
39 Chandrika G, Natesh K, Ranade D, Chugh A, Shastry P. Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling. Sci Rep 2016;6:22455. [PMID: 26940200 DOI: 10.1038/srep22455] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
40 Robinson SC, Coussens LM. Soluble mediators of inflammation during tumor development. Adv Cancer Res. 2005;93:159-187. [PMID: 15797447 DOI: 10.1016/s0065-230x(05)93005-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
41 Kikumori M, Yanagita RC, Tokuda H, Suenaga K, Nagai H, Irie K. Structural optimization of 10-methyl-aplog-1, a simplified analog of debromoaplysiatoxin, as an anticancer lead. Biosci Biotechnol Biochem 2016;80:221-31. [PMID: 26452398 DOI: 10.1080/09168451.2015.1091718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
42 Kim JM, Jung HY, Lee JY, Youn J, Lee CH, Kim KH. Mitogen-activated protein kinase and activator protein-1 dependent signals are essential for Bacteroides fragilis enterotoxin-induced enteritis. Eur J Immunol. 2005;35:2648-2657. [PMID: 16114110 DOI: 10.1002/eji.200526321] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
43 Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-7. [DOI: 10.1016/j.ccr.2005.02.013] [Cited by in Crossref: 1167] [Cited by in F6Publishing: 1082] [Article Influence: 72.9] [Reference Citation Analysis]
44 Tang L, Wang K. Chronic Inflammation in Skin Malignancies. J Mol Signal 2016;11:2. [PMID: 31051015 DOI: 10.5334/1750-2187-11-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
45 Yang L, Wang Y, Shi S, Xie L, Liu T, Wang Y, Mu H. The TNF-α-induced expression of miR-130b protects cervical cancer cells from the cytotoxicity of TNF-α. FEBS Open Bio 2018;8:614-27. [PMID: 29632814 DOI: 10.1002/2211-5463.12395] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
46 Yun Y, Han S, Park E, Yim D, Lee S, Lee CK, Cho K, Kim K. Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages. Arch Pharm Res 2003;26:1087-95. [PMID: 14723345 DOI: 10.1007/BF02994763] [Cited by in Crossref: 51] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
47 Takada Y, Aggarwal BB. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 2003;171:3278-86. [PMID: 12960358 DOI: 10.4049/jimmunol.171.6.3278] [Cited by in Crossref: 156] [Cited by in F6Publishing: 143] [Article Influence: 8.7] [Reference Citation Analysis]
48 Wheeler DL, Li Y, Verma AK. Protein Kinase C Epsilon Signals Ultraviolet Light-induced Cutaneous Damage and Development of Squamous Cell Carcinoma Possibly Through Induction of Specific Cytokines in a Paracrine Mechanism¶. Photochemistry and Photobiology 2005;81:9-18. [DOI: 10.1111/j.1751-1097.2005.tb01516.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Wheeler DL, Li Y, Verma AK. Protein Kinase C Epsilon Signals Ultraviolet Light-induced Cutaneous Damage and Development of Squamous Cell Carcinoma Possibly Through Induction of Specific Cytokines in a Paracrine Mechanism¶. Photochem Photobiol 2005;81:9. [DOI: 10.1562/2004-08-12-ra-271.1] [Cited by in Crossref: 21] [Article Influence: 1.3] [Reference Citation Analysis]
50 Yan Y, Li J, Ouyang W, Ma Q, Hu Y, Zhang D, Ding J, Qu Q, Subbaramaiah K, Huang C. NFAT3 is specifically required for TNF-α-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells. Journal of Cell Science 2006;119:2985-94. [DOI: 10.1242/jcs.03014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
51 Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431-436. [PMID: 16724054 DOI: 10.1038/nature04870] [Cited by in Crossref: 2444] [Cited by in F6Publishing: 2304] [Article Influence: 162.9] [Reference Citation Analysis]
52 Qiao Y, He H, Jonsson P, Sinha I, Zhao C, Dahlman-Wright K. AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression. J Biol Chem 2016;291:5068-79. [PMID: 26792858 DOI: 10.1074/jbc.M115.702571] [Cited by in Crossref: 48] [Cited by in F6Publishing: 30] [Article Influence: 9.6] [Reference Citation Analysis]
53 Szlosarek P, Charles KA, Balkwill FR. Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer. 2006;42:745-750. [PMID: 16517151 DOI: 10.1016/j.ejca.2006.01.012] [Cited by in Crossref: 269] [Cited by in F6Publishing: 247] [Article Influence: 17.9] [Reference Citation Analysis]
54 Nishigori C, Hattori Y, Toyokuni S. Role of Reactive Oxygen Species in Skin Carcinogenesis. Antioxidants & Redox Signaling 2004;6:561-70. [DOI: 10.1089/152308604773934314] [Cited by in Crossref: 191] [Cited by in F6Publishing: 164] [Article Influence: 11.2] [Reference Citation Analysis]
55 Shishodia S, Aggarwal BB. Nuclear Factor-κB Activation Mediates Cellular Transformation, Proliferation, Invasion Angiogenesis and Metastasis of Cancer. In: Kumar R, editor. Molecular Targeting and Signal Transduction. Boston: Kluwer Academic Publishers; 2004. pp. 139-73. [DOI: 10.1007/1-4020-7847-1_8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Reference Citation Analysis]
56 Wu ST, Sun GH, Hsu CY, Huang CS, Wu YH, Wang HH, Sun KH. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism. Exp Biol Med (Maywood). 2011;236:1022-1029. [PMID: 21856755 DOI: 10.1258/ebm.2011.011058] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
57 Szlosarek PW, Balkwill FR. Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol. 2003;4:565-573. [PMID: 12965278 DOI: 10.1016/s1470-2045(03)01196-3] [Cited by in Crossref: 262] [Cited by in F6Publishing: 81] [Article Influence: 14.6] [Reference Citation Analysis]
58 Zhou L, Tan A, Iasvovskaia S, Li J, Lin A, Hershenson MB. Ras and mitogen-activated protein kinase kinase kinase-1 coregulate activator protein-1- and nuclear factor-B-mediated gene expression in airway epithelial cells. Am J Respir Cell Mol Biol. 2003;28:762-769. [PMID: 12600818 DOI: 10.1165/rcmb.2002-0261OC] [Cited by in Crossref: 48] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
59 Azar KK, Tani M, Yasuda H, Sakai A, Inoue M, Sasagawa T. Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Human Pathology 2004;35:1376-84. [DOI: 10.1016/j.humpath.2004.08.012] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
60 Parker PJ, Brown SJ, Calleja V, Chakravarty P, Cobbaut M, Linch M, Marshall JJT, Martini S, McDonald NQ, Soliman T, Watson L. Equivocal, explicit and emergent actions of PKC isoforms in cancer. Nat Rev Cancer 2021;21:51-63. [PMID: 33177705 DOI: 10.1038/s41568-020-00310-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
61 Karin M. Tracking the road from inflammation to cancer: the critical role of IkappaB kinase (IKK). Harvey Lect 2006-2007;102:133-51. [PMID: 20166567 DOI: 10.1002/9780470593042.ch7] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
62 Nkhata KJ, Ray A, Dogan S, Grande JP, Cleary MP. Mammary tumor development from T47-D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements. Breast Cancer Res Treat 2009;114:71-83. [PMID: 18392696 DOI: 10.1007/s10549-008-9991-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
63 Ovchinnikov DA. Macrophages in the embryo and beyond: Much more than just giant phagocytes. genesis 2008;46:447-62. [DOI: 10.1002/dvg.20417] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 6.4] [Reference Citation Analysis]
64 Pérez-moreno M. When neighbourhood matters: tumour microenvironment. Clin Transl Oncol 2009;11:70-4. [DOI: 10.1007/s12094-009-0316-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
65 Benbrook DM, Lightfoot S, Ranger-Moore J, Liu T, Chengedza S, Berry WL, Dozmorov I. Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention. Gene Regul Syst Bio 2008;2:21-42. [PMID: 19784388 DOI: 10.4137/grsb.s344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
66 Jurisic V, Srdic-Rajic T, Konjevic G, Bogdanovic G, Colic M. TNF-α induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells. J Membr Biol 2011;239:115-22. [PMID: 21221555 DOI: 10.1007/s00232-010-9309-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
67 Braña MF, Gradillas A, Ovalles AG, López B, Acero N, Llinares F, Mingarro DM. Synthesis and biological activity of N,N-dialkylaminoalkyl-substituted bisindolyl and diphenyl pyrazolone derivatives. Bioorganic & Medicinal Chemistry 2006;14:9-16. [DOI: 10.1016/j.bmc.2005.09.059] [Cited by in Crossref: 70] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
68 Moizhess TG. Carcinogenesis induced by foreign bodies. Biochemistry (Mosc) 2008;73:763-75. [PMID: 18707584 DOI: 10.1134/s0006297908070043] [Cited by in Crossref: 35] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
69 Du W, Erden O, Pang Q. TNF-α signaling in Fanconi anemia. Blood Cells Mol Dis 2014;52:2-11. [PMID: 23890415 DOI: 10.1016/j.bcmd.2013.06.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
70 Mueller MM. Inflammation in epithelial skin tumours: old stories and new ideas. Eur J Cancer 2006;42:735-44. [PMID: 16527478 DOI: 10.1016/j.ejca.2006.01.014] [Cited by in Crossref: 119] [Cited by in F6Publishing: 100] [Article Influence: 7.9] [Reference Citation Analysis]
71 Sasi SP, Bae S, Song J, Perepletchikov A, Schneider D, Carrozza J, Yan X, Kishore R, Enderling H, Goukassian DA. Therapeutic non-toxic doses of TNF induce significant regression in TNFR2-p75 knockdown Lewis lung carcinoma tumor implants. PLoS One 2014;9:e92373. [PMID: 24664144 DOI: 10.1371/journal.pone.0092373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
72 Ghasemi F, Shafiee M, Banikazemi Z, Pourhanifeh MH, Khanbabaei H, Shamshirian A, Amiri Moghadam S, ArefNezhad R, Sahebkar A, Avan A, Mirzaei H. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. Pathol Res Pract 2019;215:152556. [PMID: 31358480 DOI: 10.1016/j.prp.2019.152556] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 34.0] [Reference Citation Analysis]
73 Pacifico F, Leonardi A. NF-κB in solid tumors. Biochemical Pharmacology 2006;72:1142-52. [DOI: 10.1016/j.bcp.2006.07.032] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 6.8] [Reference Citation Analysis]
74 Mathew D, Hsu W. Antiviral potential of curcumin. Journal of Functional Foods 2018;40:692-9. [DOI: 10.1016/j.jff.2017.12.017] [Cited by in Crossref: 80] [Cited by in F6Publishing: 43] [Article Influence: 26.7] [Reference Citation Analysis]
75 Gao S, Brown J, Wang H, Feng X. The role of glycogen synthase kinase 3-β in immunity and cell cycle: implications in esophageal cancer. Arch Immunol Ther Exp (Warsz) 2014;62:131-44. [PMID: 24276788 DOI: 10.1007/s00005-013-0263-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
76 Bhoumik A, Fichtman B, Derossi C, Breitwieser W, Kluger HM, Davis S, Subtil A, Meltzer P, Krajewski S, Jones N, Ronai Z. Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc Natl Acad Sci U S A 2008;105:1674-9. [PMID: 18227516 DOI: 10.1073/pnas.0706057105] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
77 Li B, Vincent A, Cates J, Brantley-Sieders DM, Polk DB, Young PP. Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res 2009;69:338-48. [PMID: 19118019 DOI: 10.1158/0008-5472.CAN-08-1565] [Cited by in Crossref: 71] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
78 Hattis D, Chu M, Rahmioglu N, Goble R, Verma P, Hartman K, Kozlak M. A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis. Crit Rev Toxicol 2009;39:97-138. [PMID: 19009457 DOI: 10.1080/10408440802307467] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
79 Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A 2006;103:10397-402. [PMID: 16798876 DOI: 10.1073/pnas.0604008103] [Cited by in Crossref: 196] [Cited by in F6Publishing: 179] [Article Influence: 13.1] [Reference Citation Analysis]
80 Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature. 2004;431:405-406. [PMID: 15385993 DOI: 10.1038/431405a] [Cited by in Crossref: 463] [Cited by in F6Publishing: 424] [Article Influence: 27.2] [Reference Citation Analysis]
81 Hensler S, Mueller MM. Inflammation and Skin Cancer: Old Pals Telling New Stories. The Cancer Journal 2013;19:517-24. [DOI: 10.1097/ppo.0000000000000010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
82 Kim S, Karin M. Role of TLR2-dependent inflammation in metastatic progression. Ann N Y Acad Sci 2011;1217:191-206. [PMID: 21276007 DOI: 10.1111/j.1749-6632.2010.05882.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
83 Pikarsky E, Ben-neriah Y. NF-κB inhibition: A double-edged sword in cancer? European Journal of Cancer 2006;42:779-84. [DOI: 10.1016/j.ejca.2006.01.011] [Cited by in Crossref: 81] [Cited by in F6Publishing: 68] [Article Influence: 5.4] [Reference Citation Analysis]
84 Das L, Vinayak M. Long-term effect of curcumin down-regulates expression of tumor necrosis factor-α and interleukin-6 via modulation of E26 transformation-specific protein and nuclear factor-κB transcription factors in livers of lymphoma bearing mice. Leukemia & Lymphoma 2014;55:2627-36. [DOI: 10.3109/10428194.2014.889824] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
85 Ge S, Zhang J, Du Y, Hu B, Zhou Z, Lou J. Dynamic changes in the gene expression profile during rat oral carcinogenesis induced by 4-nitroquinoline 1-oxide. Mol Med Rep 2016;13:2561-9. [PMID: 26860129 DOI: 10.3892/mmr.2016.4883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
86 Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, Gould D, Ayhan A, Balkwill F. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 2007;67:585-592. [PMID: 17234767 DOI: 10.1158/0008-5472.can-06-2941] [Cited by in Crossref: 266] [Cited by in F6Publishing: 154] [Article Influence: 19.0] [Reference Citation Analysis]
87 Denecker G, Ovaere P, Vandenabeele P, Declercq W. Caspase-14 reveals its secrets. J Cell Biol 2008;180:451-8. [PMID: 18250198 DOI: 10.1083/jcb.200709098] [Cited by in Crossref: 143] [Cited by in F6Publishing: 117] [Article Influence: 11.0] [Reference Citation Analysis]
88 Qu X, Dang L, Paul Seale J. Inhibitory Effect of Hypocrellin A on Protein Kinase C in Liver and Skeletal Muscle of Obese Zucker Rats. Am J Chin Med 2012;31:871-8. [DOI: 10.1142/s0192415x03001624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
89 Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409-416. [PMID: 16951987 DOI: 10.1007/s10555-006-9005-3] [Cited by in Crossref: 473] [Cited by in F6Publishing: 445] [Article Influence: 33.8] [Reference Citation Analysis]
90 Yan L, Anderson GM, DeWitte M, Nakada MT. Therapeutic potential of cytokine and chemokine antagonists in cancer therapy. Eur J Cancer. 2006;42:793-802. [PMID: 16524718 DOI: 10.1016/j.ejca.2006.01.013] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
91 Scott KA, Arnott CH, Robinson SC, Moore RJ, Thompson RG, Marshall JF, Balkwill FR. TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration? Oncogene. 2004;23:6954-6966. [PMID: 15273742 DOI: 10.1038/sj.onc.1207915] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 3.7] [Reference Citation Analysis]
92 Yin Y, Wang S, Sun Y, Matt Y, Colburn NH, Shu Y, Han X. JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells. Biomed Pharmacother 2009;63:429-35. [PMID: 19553068 DOI: 10.1016/j.biopha.2009.04.045] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
93 Møller T, James JP, Holmstrøm K, Sørensen FB, Lindebjerg J, Nielsen BS. Co-Detection of miR-21 and TNF-α mRNA in Budding Cancer Cells in Colorectal Cancer. Int J Mol Sci 2019;20:E1907. [PMID: 30999696 DOI: 10.3390/ijms20081907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
94 Liou YM, Chan CL, Huang R, Wang CA. Effect of l-caldesmon on osteoclastogenesis in RANKL-induced RAW264.7 cells. J Cell Physiol 2018;233:6888-901. [PMID: 29377122 DOI: 10.1002/jcp.26452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
95 Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 2005;175:1197-205. [PMID: 16002723 DOI: 10.4049/jimmunol.175.2.1197] [Cited by in F6Publishing: 281] [Reference Citation Analysis]
96 Monk JP, Phillips G, Waite R, Kuhn J, Schaaf LJ, Otterson GA, Guttridge D, Rhoades C, Shah M, Criswell T. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol. 2006;24:1852-1859. [PMID: 16622259 DOI: 10.1200/jco.2005.04.2838] [Cited by in Crossref: 122] [Cited by in F6Publishing: 61] [Article Influence: 8.1] [Reference Citation Analysis]
97 Wu MH, Lee WJ, Hua KT, Kuo ML, Lin MT. Macrophage Infiltration Induces Gastric Cancer Invasiveness by Activating the β-Catenin Pathway. PLoS One. 2015;10:e0134122. [PMID: 26226629 DOI: 10.1371/journal.pone.0134122] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
98 O'toole EA, van Koningsveld R, Chen M, Woodley DT. Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway. J Cell Physiol 2008;214:47-55. [DOI: 10.1002/jcp.21160] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
99 Kim S, Lee Y, Lee DH, Kim Y, Cho KH, Chung JH. Basal and UV-induced MMP-1 expression are inhibited by p53 in human dermal fibroblasts. Experimental Dermatology 2008;17:939-45. [DOI: 10.1111/j.1600-0625.2008.00729.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
100 Wang CH, Tang CW, Liu CL, Tang LP. Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway. World J Gastroenterol 2003; 9(9): 1904-1908 [PMID: 12970873 DOI: 10.3748/wjg.v9.i9.1904] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
101 Na H, Surh Y. Intracellular signaling network as a prime chemopreventive target of (–)-epigallocatechin gallate. Mol Nutr Food Res 2006;50:152-9. [DOI: 10.1002/mnfr.200500154] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
102 Wajant H. The role of TNF in cancer. Results Probl Cell Differ 2009;49:1-15. [PMID: 19137269 DOI: 10.1007/400_2008_26] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 5.9] [Reference Citation Analysis]
103 De Witte M, Shealy DJ, Nakada MT, Anderson GM. Tumor Necrosis Factor and Cancer. In: Caligiuri MA, Lotze MT, editors. Cytokines in the Genesis and Treatment of Cancer. Totowa: Humana Press; 2007. pp. 71-89. [DOI: 10.1007/978-1-59745-455-1_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Balkwill F, Joffroy C. TNF: a tumor-suppressing factor or a tumor-promoting factor? Future Oncol 2010;6:1833-6. [PMID: 21142857 DOI: 10.2217/fon.10.155] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
105 Haseman JK, Growe RG, Zeiger E, Mcconnell EE, Luster MI, Lippes J. A critical examination of the mode of action of quinacrine in the reproductive tract in a 2-year rat cancer bioassay and its implications for human clinical use. Regulatory Toxicology and Pharmacology 2015;71:371-8. [DOI: 10.1016/j.yrtph.2015.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
106 Wang Y, Liu S, Li B, Jiang Y, Zhou X, Chen J, Li M, Ren B, Peng X, Zhou X, Cheng L. Staphylococcus aureus induces COX-2-dependent proliferation and malignant transformation in oral keratinocytes. J Oral Microbiol 2019;11:1643205. [PMID: 31448061 DOI: 10.1080/20002297.2019.1643205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
107 Yang XG, Zhu LC, Wang YJ, Li YY, Wang D. Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity. Front Oncol 2019;9:887. [PMID: 31552191 DOI: 10.3389/fonc.2019.00887] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]